We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A new white paper, Undertaking Phase I Clinical Trials in Australia During a Time of Uncertainty, has been published by Nucleus Network (Nucleus), Australia's largest Phase 1 clinical trials provider.